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Many processes that are essential for mycobacterial growth are poorly understood. To facilitate genetic
analyses of such processes in mycobacteria, we and others have developed regulated expression systems that
are repressed by a tetracycline repressor (TetR) and induced with tetracyclines, permitting the construction of
conditional mutants of essential genes. A disadvantage of these systems is that tetracyclines function as
transcriptional inducers and have to be removed to initiate gene silencing. Recently, reverse TetR mutants were
identified that require tetracyclines as corepressors. Here, we report that one of these mutants, TetR r1.7,
allows efficient repression of lacZ expression in Mycobacterium smegmatis in the presence but not the absence
of anhydrotetracycline (atc). TetR and TetR r1.7 also allowed efficient silencing of the essential secA1 gene, as
demonstrated by inhibition of the growth of a conditional mutant and dose-dependent depletion of the SecA1
protein after the removal or addition, respectively, of atc. The kinetics of SecA1 depletion were similar with
TetR and TetR r1.7. To test whether silencing of secA1 could help identify substrates of the general secretion
pathway, we analyzed the main porin of M. smegmatis, MspA. This showed that the amount of cell envelope-
associated MspA decreased more than 90-fold after secA1 silencing. We thus demonstrated that TetR r1.7
allows the construction of conditional mycobacterial mutants in which the expression of an essential gene can
be efficiently silenced by the addition of atc and that gene silencing permits the identification of candidate
substrates of mycobacterial secretion systems.
The genus Mycobacterium consists of more than 100 species
found in soil or water or in association with plants, animals, or
humans (34, 44). Many of the mycobacteria found in associa-
tion with humans cause disease, and some are among the most
prominent human pathogens, including members of the Myco-
bacterium tuberculosis complex and the leprosy bacillus Myco-
bacterium leprae. Diseases caused by these pathogens remain a
major global public health problem. For example, one-third of
the world population is estimated to be infected with M. tuber-
culosis and each year approximately 9 million people develop
the active and infectious form of tuberculosis (TB) (1, 14).
Control of TB depends almost entirely on chemotherapy, be-
cause efficient vaccines preventing infection or the progression
of disease in adults are not available. Successful chemotherapy
of TB requires continuous treatment with multiple drugs for at
least 6 months and is further complicated by the spread of M.
tuberculosis strains that are resistant to several or all first-line
TB drugs (22). Active disease caused by drug-resistant M.
tuberculosis is therefore difficult to treat and associated with
high rates of mortality. New drugs against TB are thus needed
to prevent further deterioration of global public health control
due to mycobacterial infections.
Many bacterial virulence factors that facilitate host cell at-
tachment and entry or manipulation of the host immune sys-
tem are extracytoplasmic proteins (12), and secreted proteins
have been crucial to the development of vaccines against dis-
eases caused by bacterial pathogens (20). In addition, protein
secretion is also essential for the growth of many bacteria, both
in vitro and during infections. Protein export pathways have
therefore been extensively characterized in many bacterial
pathogens. More recently, the importance of protein secretion
systems, e.g., the ESAT-6 (Esx-1) (4, 5, 13, 15–17, 26, 42), the
twin-arginine translocation (Tat) (27, 33, 36), and the general
secretion (Sec) systems (2, 3, 23), for the growth and virulence
of mycobacteria has been analyzed. The Esx-1 system seems to
be a specialized transport system that mediates the export of
some of the main M. tuberculosis antigens, whereas the Tat and
Sec systems are important for the extracytoplasmic localization
of many proteins. The Esx-1 system is important for virulence
but dispensable for the growth of M. tuberculosis outside of the
host. In contrast, components of the Tat and Sec systems are
likely involved in many cellular functions and essential for the
growth of M. tuberculosis in vitro, which complicates genetic
analyses of these systems during infections.
The Sec pathway, also referred to as the general secretion
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pathway, has been most extensively studied in Escherichia coli,
where it is responsible for the transport of the majority of
extracytoplasmic proteins. The Sec machinery consists of two
cytoplasmic proteins, SecA and SecB, and three integral cyto-
plasmic membrane proteins, SecY, SecE, and SecG. SecYEG
associate in a heterotrimeric complex that forms the channel
through which unfolded substrate proteins can pass the cyto-
plasmic membrane (28). Transport through this pore is facili-
tated by accessory proteins (SecD, SecF, and YajC) (31) and
energized by the ATPase SecA (6, 25, 39). In addition to
providing the driving force for transport, SecA is also crucial
for the recognition and delivery of substrate proteins to the
pore (9) and, thus, central to the general secretion pathway.
While E. coli contains one secA gene, a number of gram-
positive bacteria and acid-fast bacilli, including M. tuberculosis
and the nonpathogenic, relatively fast-growing Mycobacterium
smegmatis, contain two secA homologs, secA1 and secA2 (2).
SecA2 is an accessory factor of the general secretion system
that promotes the transport of some proteins, e.g., superoxide
dismutase and catalase peroxidase in M. tuberculosis (3).
SecA2 is essential for the virulence of M. tuberculosis but dis-
pensable for the in vitro growth of M. smegmatis and M. tuber-
culosis (2, 3, 23). SecA1 is essential for the in vitro growth of
both species. In contrast to the SecA2 substrates, little is
known about the proteins transported by SecA1 in mycobac-
teria, because mutants harboring a secA1 deletion could not be
obtained. To facilitate the analysis of this essential protein
transport pathway in mycobacteria, we sought to construct a
conditional secA1 mutant in M. smegmatis.
In mycobacteria, conditional mutants have primarily been
generated by using regulated expression systems that silence
the target gene by transcriptional repression (for a recent re-
view, see reference 11). Five regulated expression systems
based on regulatory elements of the M. smegmatis acetamidase
gene (Ami system), genes involved in plasmid transfer in Strep-
tomyces nigrifaciens (Tra system), or genes encoding tetracy-
cline exporters in E. coli or Corynebacterium glutamicum (Tet
systems) have been developed for mycobacteria. The Tra sys-
tem is regulated by temperature and requires cultivation at
28°C, a temperature at which mycobacteria grow very slowly, to
initiate gene silencing. The Ami system and Tet systems are
controlled by short aliphatic amides (e.g., acetamide) and tet-
racyclines, respectively, and thus allow regulation under con-
ditions optimal for mycobacterial growth. However, a disad-
vantage of both systems for the construction of conditional
mutants is that acetamide and tetracycline function as inducers
of gene expression and have to be removed to initiate silencing
of the gene under investigation. The regulation of the Ami
system involves three trans factors and, therefore, seems diffi-
cult to manipulate. By contrast, the regulation of the three
mycobacterial Tet systems is mediated by a single transcrip-
tional repressor of the well-characterized class of tetracycline
repressors (TetRs). Recently, mutant TetRs have been identi-
fied that permit gene silencing in E. coli (38) and Bacillus
subtilis (18) by the addition instead of removal of tetracyclines.
Here, we report that one of these reverse TetRs (revTetRs)
allows efficient gene silencing and the construction of a condi-
tional secA1 mutant in M. smegmatis.
MATERIALS AND METHODS
Bacterial strains, media, reagents, and molecular biology techniques. The
bacteria and plasmids used in this study are listed in Table 1. The plasmids were
generated by using standard cloning procedures. The correct sequence of all
cloned PCR fragments was confirmed by DNA sequencing. The cloning strate-
gies and sequences of the oligonucleotides used for cloning of the different
plasmids are available upon request. Mycobacterium smegmatis was grown at
37°C on Difco 7H11 agar (BD) or in Difco Middlebrook 7H9 broth (BD) with
0.2% (vol/vol) glycerol and 0.05% (vol/vol) Tween 80. Antibiotics were added,
where appropriate, at 50 g/ml (hygromycin B; Calbiochem) and 15 g/ml
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Reference
Strains
M. smegmatis mc2155 Electroporation-proficient mutant of M. smegmatis mc26 40
MSE10 Hygr mc2155 derivative in which secA1 is controlled by Pmyc1tetO This work
MSE11 Kanr mc2155 derivative containing tetR integrated into L5 attB This work
MSE12 Kanr mc2155 derivative containing pTEK-4S0X expressing tetR r1.7 This work
MSE13 Kanr MSE10 derivative containing tetR integrated into L5 attB This work
MSE14 Kanr MSE10 derivative containing pTEK-4S0X expressing tetR r1.7 This work
Plasmids
pKIsecA1 pSE100 derivative in which the mycobacterial origin of replication was replaced by the first 641
bp of secA1
This work
pMC1s Derivative of pMV306K with tetR under the control of Psmyc 10
pME0L1 Derivative of pMS2 with lacZ under the control of Pmyc1tetO 10
pME1mL1 Derivative of pMS2 with lacZ under the control of Pmyc1tetO and tetR under the control of Psmyc 10
pMS2 Hygr; a shuttle vector containing origins of replication for E. coli (pMB1) and mycobacteria
(pAL500) and a multiple cloning site flanked by two transcriptional terminators
19
pMV306K Kanr; single-copy-integrating plasmid which inserts into L5 attB 43
pSE100 pMS2 derivative containing Pmyc1tetO This work
pTC-0X1L Derivative of pMV306K containing lacZ expressed from Pmyc1tetO This work
pTE-1M0X Derivative of pMS2 with tetR expressed by Pimyc This work
pTE-1S0X Derivative of pMS2 with tetR expressed by Psmyc This work
pTE-4M0X Derivative of pMS2 with tetR r1.7 expressed by Pimyc This work
pTE-4S0X Derivative of pMS2 with tetR r1.7 expressed by Psmyc This work
pTEK-4S0X Kanr; derivative of pTE-4S0X This work
pWH192515A/17G/25V E. coli plasmid expressing tetR r1.7 38
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(kanamycin A; Sigma). Anhydrotetracycline (atc) was obtained from Sigma. The
preparation of electrocompetent cells, conduction of electroporation, and prep-
aration of the genomic DNA of M. smegmatis were performed as described
previously (10).
-Galactosidase assays. The levels of repression and induction with atc were
determined after the cotransformation of M. smegmatis mc2155 with two plas-
mids, one that expressed wild-type (wt) TetR or the revTetR (TetR r1.7) and
another that contained lacZ downstream of the TetR-responsive promoter
Pmyc1tetO. From each transformation, three single colonies were inoculated sep-
arately into 2 ml of 7H9 medium containing kanamycin and hygromycin (TetR
r1.7). After shaking at 37°C for 44 to 48 h, the bacteria were diluted 100-fold into
1 ml fresh media in 96-square-well plates (Beckman). After shaking at 37°C for
20 to 24 h, the optical densities at 580 nm (OD580) were measured. In a black
96-well plate, 100 l bacteria were then mixed with 10 l of 330 M
5-acetylaminofluorescein di--D-galactopyranoside (Invitrogen) (35). The plate
was incubated in the dark for 3 h at 30°C and the fluorescence was measured at
515 nm after excitation at 485 nm using a Spectramax M2 plate reader (Molec-
ular Devices). The fluorescence intensities were normalized to the cell densities
and reported as relative fluorescence units. All measurements were repeated at
least twice.
Replacement of the native secA1 promoter with Pmyc1tetO. The suicide plasmid
pKIsecA1 was generated by amplifying the first 641 bp of secA1 by PCR, restric-
tion of the amplicon with SphI and NotI, and ligation into the equally restricted
pSE100. pKIsecA1 was electroporated into M. smegmatis mc2155, and transfor-
mants were selected on 7H11 agar plates supplemented with hygromycin B. The
site-specific integration of pKIsecA1 was confirmed by PCR using primers P117
(5-AAGCGGAAGAGCGCCCAATAC-3) and P120 (5-CCGCGGAAATAT
TCGCCACTTAC-3), as well as primers P154 (5-GTCTTTGACGGCTGACA
GAG-3) and P155 (5-GCGTTGTTCAGGTAGCTGAC-3).
Culture conditions for tetR-containing secA1 mutants. Mutants containing wt
TetR were maintained in the presence of 10 ng/ml atc to allow the expression of
secA1. Transcriptional silencing of secA1 was initiated by washing cells grown to
a density of OD580 of2 absorbance units per cm [AU/cm] three times with 7H9
medium free of atc and diluting these bacteria into 7H9 medium without atc.
Mutants containing revTetR were maintained in the absence of atc; to silence
secA1, atc was added to new cultures at the concentrations indicated. To avoid
the inactivation of atc, cultures containing atc were protected from light by
wrapping the culture vessels with aluminum foil.
Preparation of cell lysates and subcellular fractions. M. smegmatis was har-
vested by centrifugation and washed with phosphate-buffered saline (128 mM
NaCl, 8.5 mM Na2HPO4, 3.5 mM KCl, 1.5 mM KH2PO4, pH 7.4). The cells were
resuspended at an OD580 of 10 AU/cm in phosphate-buffered saline supple-
mented with protease inhibitors (Roche Applied Science), and 1 ml of the
suspension was transferred into a screw-cap vial containing approximately 350 l
of 0.1-mm zirconia/silica beads (BioSpec). The cells were broken by shaking in a
Precellys 24 homogenizer (Bertin Technologies) at 6,500 rpm for 20 s three
times, with 5-min incubations on ice in between. Total lysates were obtained after
removing beads and unbroken cells by centrifugation at 8,000  g for 20 s. For
detection of MspA, total lysates were centrifuged at 20,800  g for 45 min at 4°C
in an Eppendorf 5417R centrifuge to separate the soluble (cytoplasm) and
insoluble (cell wall) fractions.
Anti-SecA1 and anti-SecA2 antibody production. Antipeptide antibodies for
each SecA in mycobacteria (SecA1 or SecA2) were prepared by using peptides
specific for each of the proteins. The peptides were synthesized, conjugated to
keyhole limpet hemocyanin, and used to immunize New Zealand White rabbits
at Quality Controlled Biochemicals (Hopkinton, MA). For anti-SecA1 antibod-
ies, the peptide RLRERGLDPVETPEEYEA was used (this peptide sequence is
identical in M. tuberculosis and M. smegmatis SecA1). For anti-SecA2 antibodies,
the peptide LDHEPGLDLSKLARPT was used (this peptide was designed
from M. tuberculosis SecA2, and the corresponding region in M. smegmatis
SecA2 has four amino acid substitutions). The antibodies were purified by
affinity chromatography.
SDS-PAGE and quantitative Western blot analysis. Cell lysates were mixed
with sodium dodecyl sulfate (SDS) sample buffer and incubated in a boiling
water bath for 5 min for analyses of the levels of TetR or SecA1 and incubated
for 15 min for analyses of the levels of MspA. The proteins were separated by
10% SDS-polyacrylamide gel electrophoresis (PAGE) and electrotransferred to
a Protran BA83 nitrocellulose membrane (Whatman) at 0°C with a constant
voltage of 120 V in transfer buffer (192 mM glycine, 25 mM Tris, 20% [vol/vol]
methanol) for 2 h. Affinity-purified polyclonal rabbit antibodies against SecA1 or
SecA2 were used at a 1:10,000 dilution in TBST (150 mM NaCl, 10 mM Tris-Cl,
0.05% [vol/vol] Tween 20, pH 8.0). Polyclonal rabbit antibodies against MspA
(29) and AhpC (7) were used at a 1:50,000 dilution and a 1:30,000 dilution,
respectively, in TBST. For the quantification of TetR, a mixture of hybridoma
supernatant containing monoclonal murine antibodies (32) was used at a 1:100
dilution in TBST. Horseradish peroxidase-linked secondary antibodies against
rabbit immunoglobulin G or mouse immunoglobulin G (GE Healthcare) were
used at a 1:30,000 dilution in TBST. Immobilon Western horseradish peroxidase
substrates (Millipore) and BioMax MR films (Kodak) were used for enhanced
chemiluminescence detection. The densitometry of Western blots was performed
by scanning films with an Epson perfection 2450 photo scanner and analyzing the
resultant 16-bit gray scale TIFF images with Quantity One software (Bio-Rad).
RESULTS
Regulation of -galactosidase expression by TetR and TetR
r1.7 inM. smegmatis. To determine whether revTetRs function
in mycobacteria, we measured the activity of TetR r1.7, one of
the most efficient revTetRs, which contains the mutations
E15A, L17G, and L25V (38), in Mycobacterium smegmatis by
using a -galactosidase reporter assay. For this assay, the
TetR-controlled lacZ gene was integrated into the M. smeg-
matis chromosome and TetR and TetR r1.7 were expressed
episomally (Fig. 1A). The repression of -galactosidase activ-
ities was measured in strains expressing TetR or TetR r1.7 by
using promoters with high (Psmyc) or lower (Pimyc) activities
(19). Initially, the bacteria were either grown without atc or
with 30 ng/ml atc (Fig. 1B). The expression of wt TetR using
either Pimyc or Psmyc resulted in efficient repression of lacZ, but
the induction of -galactosidase with atc was detected only
when TetR was expressed using Pimyc. The repression of lacZ
by TetR r1.7 occurred only in the presence of atc and only in
bacteria containing TetR r1.7 under the control of Psmyc. The
maximal regulation factors were 39 for wt TetR and 17 for
TetR r1.7. Next, we measured -galactosidase activities after
the cultivation of M. smegmatis with atc concentrations ranging
from 1 to 200 ng/ml (Fig. 1C). These experiments confirmed
that the regulation of lacZ by atc was efficient only when wt
TetR was expressed by Pimyc and TetR r1.7 by Psmyc. In both
strains, the regulation was atc dose responsive. Induction by
TetR reached saturation at 10 ng/ml atc and repression by
TetR r1.7 was maximal with as little as 10 ng/ml atc. These
experiments demonstrated that TetR r1.7 allows efficient, atc
dose-dependent regulation of gene expression in M. smegmatis
if expressed by a strong mycobacterial promoter.
Expression of TetR and TetR r1.7 in M. smegmatis. To test
whether the requirement for a strong promoter for TetR r1.7-
mediated repression was caused by small in vivo protein
amounts, we compared the steady-state levels of TetR and
TetR r1.7. Quantitative Western blots were performed using
protein lysates from log-phase cultures of M. smegmatis trans-
formed with pTE-1S0X or pTE-4S0X (OD580 at 1.2 to 1.25
AU/cm). The TetR levels were quantified densitometrically,
using AhpC, the M. smegmatis alkylhydroperoxidase, for nor-
malization, and known amounts of purified TetRs for quanti-
fication. This revealed that each mg of total lysate contained
7.4  2.4 ng TetR but only 1.5  0.9 ng TetR r1.7 (Fig. 2). The
amounts of TetR and TetR r1.7 in M. smegmatis expressing the
respective repressors using Pimyc were both below the limit of
detection (data not shown). The Western blot analyses thus
demonstrated that the steady-state level of TetR r1.7 was ap-
proximately one-fifth of that of wt TetR when expression was
driven by Psmyc in otherwise identical M. smegmatis strains.
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Construction of conditional secA1 mutants. SecA1 was
shown to be essential for the growth of M. smegmatis based on
the inability to obtain a secA1 deletion mutant via allelic ex-
change (2). To obtain a mutant in which the expression of
SecA1 can be controlled by TetRs, we generated the suicide
plasmid pKIsecA1 by cloning a PCR product containing a
Shine-Dalgarno sequence followed by the first 641 bp of the
5 coding region of M. smegmatis secA1 into pSE100 down-
stream of the TetR-responsive promoter Pmyc1tetO (Fig. 3A).
pKIsecA1 was transformed into M. smegmatis mc2155, and
chromosomal DNA was isolated from hygromycin-resistant
clones. Analyses by PCR demonstrated that Pmyc1tetO was
inserted into the chromosome upstream of secA1 (Fig. 3B). In
the absence of tetR, this mutant, named MSE10, showed nor-
mal growth compared to that of M. smegmatis mc2155 (data not
shown).
To achieve silencing of secA1, MSE10 was transformed with
plasmid pMC1s, which integrates a Psmyc-tetR expression cas-
sette into the mycobacteriophage L5 att site, or with the epi-
somal plasmid pTEK-4S0X, which expresses TetR r1.7 using
the promoter Psmyc, generating strains MSE13 and MSE14,
respectively (Fig. 3A). As controls, strains MSE11 and MSE12
FIG. 1. Regulation of -galactosidase expression in M. smegmatis
by wt TetR and revTetR. (A) Schematic of the assay system. wt TetR
is depicted by gray ovals and revTetR by striped ovals. The tetO
operator sites that bind the repressors are shown as black boxes in the
TetR-responsive promoter Pmyc1tetO. -Galactosidase was expressed
from a lacZ gene located downstream of Pmyc1tetO and integrated into
the M. smegmatis chromosome at the mycobacteriophage L5 att site.
Expression of wt TetR and TetR r1.7 was achieved using episomal
plasmids containing the respective tetR genes downstream of a strong
(Psmyc) or weaker (Pimyc) promoter. For wt TetR, the expression of
lacZ is switched on after the addition of atc, depicted by dark gray
hexagons (left side). For revTetR, the addition of atc mediates repres-
sion of lacZ transcription (right side). (B) Repression and induction
with TetR, TetR r1.7, and atc. -Galactosidase activities in relative
fluorescence units (RFU) were measured in the absence () or pres-
ence () of 30 ng/ml atc as described in Materials and Methods. The
light gray bars represent -galactosidase activities in the absence of atc,
whereas the dark gray bars show -galactosidase activities after the
addition of atc. Promoters Psmyc and Pimyc were used to achieve high or
low expression, respectively, of TetRs. Error bars represent the stan-
dard errors of the means. (C) Dose responsiveness of -galactosidase
expression regulated by wt TetR and TetR r1.7 measured in relative
fluorescence units (RFU). Regulation mediated by low-level expres-
sion of TetR is depicted by filled circles for wt and filled gray triangles
for TetR r1.7. Regulation mediated by high-level expression of TetR is
shown as open circles for wt and open gray triangles for TetR r1.7. atc
concentrations ranging from 1 to 200 ng/ml were used to regulate the
transcription of lacZ. Error bars represent the standard deviations of
the means.
FIG. 2. Steady-state protein levels of TetR and TetR r1.7 in M.
smegmatis. Total lysates from M. smegmatis strains transformed with
either pTE-1S0X (expressing wt TetR from the strong promoter Psmyc)
or pTE-4S0X (expressing TetR r1.7 from the strong promoter Psmyc)
were loaded on a 10% SDS-PAGE gel in 1:4 serially decreasing
amounts for quantitative Western blot analysis using antibodies against
TetR (	-TetR). Purified wt TetR and TetR r1.7 proteins were also
loaded in 1:4 serially decreasing amounts on the same gel for the
calibration of standard curves. Different amounts of wt TetR- and
TetR r1.7-containing lysates were used to obtain signal strengths in or
near the linear range comparable with that of the purified standards so
that quantification could be performed. AhpC was used as the loading
control. Positions of the molecular weight markers are indicated on the
left.
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were generated by transforming M. smegmatis mc2155, which
contained secA1 under the control of its native promoter, with
pMC1s and pTEK-4S0X, respectively. The four strains were
streaked onto 7H11 agar plates containing 50 ng/ml atc or no
atc. The control strains grew normally under both conditions,
but growth of MSE13 was observed only in the presence of atc,
whereas MSE14 grew only in the absence of atc (Fig. 4). This
experiment confirmed the essentiality of secA1 for the growth
of M. smegmatis on agar plates and demonstrated that efficient
growth inhibition was achieved with both wt TetR and
TetR r1.7.
Dose dependency of growth inhibition and SecA1 depletion.
We next determined whether growth inhibition of strains
MSE13 and MSE14 could also be achieved in liquid culture
and was atc dose dependent. The mutants were first grown
under permissive conditions (i.e., MSE13 was grown in 7H9
medium containing 10 ng/ml atc and MSE14 was grown with-
out atc), washed, and diluted into fresh media containing no
atc or 0.03 to 30 ng/ml atc at threefold-increasing concentra-
tions (Fig. 5A). The growth of MSE13 was inhibited in media
containing less than 1 ng/ml atc, whereas the growth of MSE14
was impaired in media containing more than 1 ng/ml atc. The
extent of growth inhibition was atc concentration dependent in
both strains.
The dose dependency of secA1 silencing was examined by
quantitative Western blot analyses measuring SecA1 protein
FIG. 3. Construction and verification of conditional secA1 mutants of M. smegmatis. (A) Schematic overview of strain construction. The suicide
plasmid pKIsecA1 was electroporated into M. smegmatis mc2155 and integrated at the secA1 locus via homologous recombination, inserting the
TetR-responsive promoter Pmyc1tetO before secA1 and generating strain MSE10. wt TetR or TetR r1.7 was subsequently introduced into MSE10
to generate the conditional secA1 mutants MSE13 and MSE14, respectively; TetR or TetR r1.7 was also introduced into mc2155 to generate the
control strains MSE11 and MSE12, respectively. 1881 and 1883 stand for MSMEG1881 and MSMEG1883, genetic loci upstream and downstream
of secA1 on the genome of M. smegmatis mc2, according to The Institute for Genomic Research. PCR primers 154, 155, 117, and 120 were used
for verifying the genotype of MSE10. (B) Confirmation of the MSE10 genotype by PCR. Genomic DNA prepared from mc2155 or MSE10 was
used in PCRs with the indicated primer pairs, and the products were analyzed on a 1% agarose gel. No PCR product was expected using primers
117 plus 120 and the genomic DNA of mc2155; the size of the expected product from primers 117 plus 120 and MSE10 was 3.4 kb. Primers 154
plus 155 were expected to give a 1.0-kb product from mc2155 and a 4.3-kb product from MSE10. The arrows indicate the locations of the products.
DNA molecular weight markers are shown on the left.
FIG. 4. Growth of secA1 conditional silencing mutants on agar plates in
the absence () and presence () of atc. wt-TetR-regulated strain MSE13,
TetR r1.7-regulated strain MSE14, and the respective control strains MSE11
and MSE12 were streaked onto 7H11 plates without atc or with 50 ng/ml atc,
and pictures of the plates were taken after 3 days of incubation at 37°C.
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levels in bacterial lysates (Fig. 5B and C). The SecA1 levels in
control strains MSE11 and MSE12 were not significantly dif-
ferent from that in M. smegmatis mc2155 (data not shown). At
atc concentrations of 10 ng/ml or higher, the SecA1 levels in
MSE13 were 300% of that in the control strain MSE11 and
a similar increase in SecA1 expression was observed in MSE14
in the absence of atc. In MSE13, the SecA1 levels decreased
with decreasing atc concentrations. At 3 ng/ml atc, the SecA1
levels were reduced to 77% of the level in the control, at 1
ng/ml atc to 14%, and at less than 0.3 ng/ml, SecA1 was below
the limit of detection. By contrast, in MSE14, the SecA1 levels
decreased with increasing atc concentrations. The SecA1
amounts were reduced to 77% at 3 ng/ml atc and 13% at 10
ng/ml and reached the limit of detection at 30 ng/ml. Taken
together, these experiments demonstrated that both wt TetR
and TetR r1.7 efficiently silenced secA1 and allowed dose-
dependent regulation of SecA1 protein levels over a range of
at least two orders of magnitude. The impact of SecA1 deple-
tion on growth confirmed that secA1 is also essential for the
growth of M. smegmatis in liquid culture.
FIG. 5. atc dose dependency of growth inhibition and SecA1 depletion in conditional secA1 mutants. (A) Growth inhibition. Cultures of M.
smegmatis strains were initially obtained in media allowing secA1 expression, washed, and diluted into fresh media containing different atc
concentrations at the starting OD580 of 0.02 AU/cm. The cultures were agitated at 250 rpm at 37°C for 21 h, and bacterial growth was measured
by the OD580. (B) SecA1 Western blot analysis. Total lysates of M. smegmatis were prepared from cultures harvested at 21 h from the above
experiment and analyzed by 10% SDS-PAGE, followed by Western blotting using antibodies against SecA1 and SecA2 (	-SecA1 and 	-SecA2).
SecA2 was used as the loading control. Positions of the protein molecular weight markers are indicated on the left. (C) Quantification of the
Western blot signals. The signal strengths of the SecA1 and SecA2 bands were determined by densitometry, and the loading-adjusted SecA1
expression levels were calculated by dividing the SecA1 level by the SecA2 level. In order to compare the two groups of strains that were regulated
by wt TetR or TetR r1.7 on the same graph, the loading-adjusted SecA1 levels for all samples of MSE11 and MSE13 were expressed as the
percentages of the level for MSE11 at 0 ng/ml atc, and the loading-adjusted SecA1 levels for all samples of MSE12 and MSE14 were expressed
as the percentages of the level for MSE12 at 0 ng/ml atc. RU, relative units.
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Kinetics of growth inhibition and SecA1 depletion. To de-
termine the kinetics of growth inhibition and SecA1 depletion,
strains MSE13 and MSE14 were grown in permissive media,
washed, and diluted into new media without or with atc (10
ng/ml for MSE13 and 40 ng/ml for MSE14). Bacterial growth
was monitored by OD measurements, and samples of cultures
were harvested every 4 h in the early log phase and every 6 h
in the mid-log to stationary phases for the detection of SecA1
levels in total lysates by quantitative Western blotting. For both
MSE13 and MSE14, the growth rates started to decline approx-
imately 12 h after transfer into nonpermissive media (Fig. 6A);
the culture densities peaked at 21 to 24 h and decreased to 0.05
to 0.11 AU/cm in later growth phases. Samples were taken at
the indicated time points and analyzed by quantitative Western
blotting (Fig. 6B and C). At the start of the time course, the
SecA1 level in MSE13 was 300% of that in the control strain
MSE11, and it decreased to 200% at 4 h after atc removal,
73% at 8 h, and 5% at 12 h and was below the limit of detection
at 18 h and the later time points. The SecA1 level in MSE14
was 450% of that in the control strain MSE12 at the begin-
ning of the experiment, and it decreased to 350% at 4 h after
atc addition,150% at 8 h, and 12% at 12 h and was below the
limit of detection at 18 h and later time points. The kinetics of
growth inhibition and SecA1 depletion were, thus, similar in
MSE13 and MSE14.
Impact of secA1 silencing on steady-state levels of cell wall-
associated MspA. In E. coli, the transport of porins across the
cytoplasmic membranes is secA dependent (30). To begin the
identification of SecA1 substrates in M. smegmatis, we analyzed
the impact of secA1 silencing on the steady-state level of cell
wall-associated MspA, the major porin of M. smegmatis (41).
MSE14 was grown in the same manner as in the dose-depen-
dency experiments in media containing different atc concen-
trations for 21 h, when the bacterial growth as measured by
OD reached a plateau. The cell wall fractions of the bacterial
lysates were then examined for MspA by quantitative Western
FIG. 6. Kinetics of growth inhibition and SecA1 depletion. (A) Growth inhibition. Cultures of M. smegmatis strains were grown in media
allowing secA1 expression, washed, and diluted into fresh media containing no atc () or 40 ng/ml atc (). Bacterial growth was monitored in the
following 48 h by measuring the OD580. (B) SecA1 Western blot analysis. Samples of bacterial cultures in the experiment described above were
harvested at the times indicated, and total lysates were prepared and analyzed by 10% SDS-PAGE, followed by Western blot analysis using
antibodies against SecA1 and SecA2 (	-SecA1 and 	-SecA2). SecA2 was used as the loading control. Positions of the protein molecular markers
are indicated on the left. (C) Quantification of the Western blot signals, performed as described in the legend to Fig. 5C.
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blotting (Fig. 7). At atc concentrations of 1 ng/ml or lower, i.e.,
conditions that did not cause a reduction of the SecA1 level
compared to the level in the reference strain MSE12 (Fig. 6B
and C), the MspA level in the cell wall fraction was almost
identical to the level in the control strain (96% to 116%). As
the atc concentration was increased to 3 ng/ml or higher, when
SecA1 was efficiently silenced, the MspA level in the cell wall
fraction decreased to 74% at 3 ng/ml atc, 21% at 10 ng/ml atc,
and 1% at 30 ng/ml atc, suggesting that MspA was secreted in
an SecA1-dependent manner. MspA was not detected in the
cytosolic fraction (data not shown) even when SecA1 was si-
lenced and MspA levels had decreased in the cell wall fraction,
suggesting that MspA did not accumulate intracellularly upon
secA1 silencing.
DISCUSSION
Regulated bacterial expression systems have primarily been
used for two applications: the production of proteins and the
analysis of genes that are essential for bacterial growth. Protein
purification is greatly facilitated by expression systems that
allow controlled overproduction of the desired protein after
the initial propagation of bacteria under conditions that sup-
press overexpression. The expression systems best suited for
the production of proteins are, therefore, systems that can be
turned on by the addition of an inducer to a bacterial culture.
Such inducible expression systems have also been useful for the
analysis of in vivo gene functions (for an example, see refer-
ence 45). However, if the silencing of a gene is the goal, such
expression systems are not ideal, because the inducer has to be
removed to achieve silencing. Removal of the inducer from the
bacteria usually requires procedures (e.g., centrifugation and
washing) that may affect the biological process under investi-
gation, can be difficult to achieve in some assays (e.g., during
oxygen deprivation or infections of eukaryotic cells or animals)
and may be slow in some cases due to intracellular accumula-
tion of the inducer or its binding to the bacterial cell envelope.
The expression systems best suited for gene silencing are there-
fore systems that can be turned off by the addition of a co-
repressor.
RevTetRs, which require tetracyclines as corepressors and
allow the repression of gene expression by the addition of
tetracyclines to bacterial cultures, have recently been isolated
(18, 38). We used lacZ reporter gene measurements and a
conditional M. smegmatis secA1 mutant to demonstrate that
one of these repressors, TetR r1.7, also allows the silencing of
mycobacterial gene expression. Expression of TetR r1.7 by the
strong promoter Psmyc (19) resulted in a 17-fold-lower -galac-
tosidase activity in the presence of 30 ng/ml atc than in the
absence of atc. The repression of -galactosidase activity was
atc dose dependent and maximal at 10 to 30 ng/ml atc, con-
centrations that are up to 50-fold lower than the atc concen-
tration of 500 ng/ml that reduced the growth of M. smegmatis
(10). This demonstrated that TetR r1.7 can be used to effi-
ciently silence gene expression in M. smegmatis by the addition
of subinhibitory concentrations of atc.
Silencing of -galactosidase activities by TetR r1.7 was not
observed if the repressor was expressed using the weaker pro-
moter Pimyc (19). In contrast, repression of -galactosidase by
wt TetR was efficient in strains that contained this repressor
under the control of either promoter, and expression of wt
TetR by the strong promoter even interfered with efficient
induction in response to 200 ng/ml atc. Quantitative Western
blot analyses revealed that expression from Psmyc led to a
fivefold-higher steady-state level of wt TetR compared to that
of TetR r1.7, and the steady-state levels of wt TetR and TetR
r1.7 expressed from Pimyc were both substantially lower than
the levels expressed from Psmyc. Repression by wt TetR was,
thus, efficient at steady-state levels below those that led to
repression by TetR r1.7, suggesting that wt TetR is more effi-
cient in M. smegmatis than TetR r1.7. The lower efficiency of
TetR r1.7 also prevented efficient silencing in strains that ex-
pressed this variant chromosomally (data not shown), presum-
ably because multiple gene copies were necessary to achieve
sufficient steady-state levels of the repressor required for effi-
cient repression. It is unknown if the lower steady-state level of
TetR r1.7 was caused by a lower half-life of the protein in vivo
or less-efficient translation of its mRNA. Mycobacterial
pAL5000-derived episomes are stable over many generations
even in the absence of selection (S. Ehrt, unpublished data).
The requirement for episomal expression might, therefore, not
significantly limit the use of TetR r1.7 in mycobacteria.
We next constructed an M. smegmatis mutant in which tran-
scription of the essential secA1 was brought under the control
FIG. 7. Impact of secA1 silencing on steady-state levels of cell wall-
associated MspA. (A) MspA Western blot analysis. Cell wall-associ-
ated proteins were prepared from MSE12 and MSE14 cultures grown
for 21 h with different atc concentrations as described in Materials and
Methods and analyzed by 10% SDS-PAGE, followed by Western blot
analysis using antibodies against MspA and AhpC (	-MspA and
	-AhpC). AhpC was used as the loading control. Positions of the
protein molecular markers are indicated on the left. (B) Quantification
of Western blot signals. The signal strengths of the MspA and AhpC
bands were determined by densitometry, and the loading-adjusted
MspA levels were calculated by dividing the MspA level by the AhpC
level. RU, relative units.
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of Pmyc1tetO and used this mutant to test whether TetR r1.7
permits conditional silencing of secA1. The addition of atc
inhibited the growth of this mutant both on agar plates and in
liquid culture, and the growth inhibition in liquid culture was
atc dose dependent. In contrast, the growth of the Pmyc1tetO-
secA1 mutant containing wt TetR required atc both on agar
plates and in liquid culture. The kinetics of SecA1 depletion
were similar after secA1 silencing with wt TetR and TetR r1.7.
These experiments demonstrate that both wt TetR and TetR
r1.7 permit the construction of mycobacterial mutants in which
the function of essential genes can be studied by conditional
gene silencing. They furthermore confirm the essentiality of
secA1 for the growth of M. smegmatis on agar plates and
demonstrate that secA1 is essential for growth in liquid culture
as well.
The general secretion pathway has been extensively studied
in E. coli, but relatively little is known about its function in
mycobacteria, even though this protein secretion pathway is
likely important not only for in vitro growth but also for the
virulence of mycobacterial pathogens (3, 23). To test whether
the identification of substrates of the general secretion path-
way could be facilitated by conditional silencing of secA1, we
measured the amount of cell wall-associated MspA before and
after secA1 silencing. A 
90-fold, atc dose-dependent reduc-
tion of cell wall-associated MspA was detected after silencing
secA1 with TetR r1.7 and atc. In contrast, the addition of atc to
the control strain did not affect the amount of cell wall-asso-
ciated MspA significantly. These experiments, therefore, sug-
gest that the transport of MspA across the cytoplasmic mem-
brane is SecA1 dependent. We could not detect intracellular
accumulation of MspA as a result of secA1 silencing, suggest-
ing that mspA translation and secretion are coupled or that
intracellular MspA is efficiently degraded.
Many genes that are essential for the optimal growth of M.
tuberculosis on agar plates have recently been identified by
genome-wide mutagenesis (24, 37). More than a third of the
approximately 600 genes postulated to be essential for the
optimal growth of M. tuberculosis are of unknown function. By
contrast, only 4% of all essential B. subtilis genes are of un-
known function (21), suggesting that significant gaps exist in
our understanding of essential gene functions in mycobacteria.
Functional orthologues for 78% of essential M. tuberculosis
genes have been retained in the genome of M. leprae, even
though its genome has undergone extensive degeneration and
contains functional orthologues of only 40% of all M. tubercu-
losis genes (8, 37). This suggests that most essential genes are
conserved among all mycobacteria. The fast-growing, non-
pathogenic M. smegmatis might therefore be a valuable surro-
gate host for the analysis of essential mycobacterial gene func-
tions. We developed a gene expression system that allows the
efficient silencing of an essential gene by the addition of atc to
the culture of M. smegmatis. We further demonstrated that
conditional gene silencing allows the identification of candi-
date substrates of the general secretion pathway in mycobac-
teria. This suggests that a combination of dose-responsive si-
lencing of essential genes with genomics approaches, for
example, transcriptome and proteome analyses, could be used
to increase our understanding of protein secretion and other
processes essential for the growth of mycobacteria.
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